Table 1.
Viral aetiology of respiratory infections according to type of surveillance scheme, country region, and patients’ age group and gender. Ecuador, 2009–2016.
| No. specimens | A(H1N1)p | A(H3N2) | A other/not subtyped | B | RSV | Parainfluenza | Adenovirus | hMPVa | Co-infectionsb | No virus | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | 41,172 | 9.8% (9.5–10.1%) | 2.6% (2.5–2.8%) | 0.7% (0.6–0.8%) | 1.2% (1.1–1.3%) | 9.5% (9.2–9.8%) | 1.8% (1.7–1.9%) | 0.6% (0.5–0.7%) | 0.5% (0.4–0.6%) | 0.3% (0.2–0.4%) | 73.2% (72.8–73.6%) |
| Surveillance scheme and regionc | |||||||||||
| Universal surveillanced | 12,765 | 20.3% | 3.0% | 1.8% | 0.1% | 4.4% | 1.0% | 0.4% | – | 0.1% | 68.7% |
| Coast | 8138 | 13.2% | 3.4% | 2.6% | 0.2% | 6.9% | 1.5% | 0.7% | – | 0.2% | 71.3% |
| Sierra | 4251 | 33.1% | 2.3% | 0.3% | 0.0% | 0.1% | 0.1% | 0.0% | – | 0.0% | 64.1% |
| Sentinel surveillanced | 28,407 | 5.1% | 2.4% | 0.1% | 1.7% | 11.7% | 2.2% | 0.6% | 0.6% | 0.3% | 75.2% |
| Coast | 11,317 | 2.7% | 1.7% | 0.2% | 1.0% | 14.0% | 2.5% | 0.5% | 0.2% | 0.3% | 77.0% |
| Sierra | 16,935 | 6.7% | 3.0% | 0.1% | 2.2% | 10.3% | 2.0% | 0.7% | 0.9% | 0.2% | 73.9% |
| Gendere | |||||||||||
| Male | 22,228 | 9.6% | 2.5% | 0.7% | 1.2% | 10.1% | 1.9% | 0.6% | 0.5% | 0.3% | 72.6% |
| Female | 18,880 | 9.9% | 2.7% | 0.6% | 1.2% | 8.8% | 1.7% | 0.5% | 0.4% | 0.2% | 73.9% |
| Age groupf | |||||||||||
| 0–1 months | 2653 | 0.8% | 1.2% | 0.4% | 0.4% | 22.5% | 2.1% | 0.2% | 0.2% | 0.3% | 72.0% |
| 2–5 months | 4440 | 1.1% | 1.0% | 0.1% | 1.0% | 18.9% | 2.7% | 0.5% | 0.5% | 0.4% | 73.7% |
| 6–11 months | 4314 | 2.4% | 2.3% | 0.1% | 1.1% | 18.4% | 3.2% | 0.7% | 0.6% | 0.5% | 70.7% |
| 1–4 years | 12,884 | 5.4% | 2.7% | 0.9% | 1.1% | 11.7% | 2.4% | 1.0% | 0.7% | 0.3% | 73.8% |
| 5–17 years | 4603 | 19.4% | 3.0% | 1.1% | 1.8% | 2.2% | 1.1% | 0.5% | 0.2% | 0.1% | 70.5% |
| 18–39 years | 4726 | 24.1% | 3.0% | 0.8% | 1.1% | 0.4% | 0.4% | 0.0% | 0.1% | 0.0% | 70.0% |
| 40–64 years | 4115 | 21.8% | 3.2% | 0.7% | 1.3% | 0.5% | 0.4% | 0.1% | 0.3% | 0.0% | 71.7% |
| 65 + years | 3424 | 7.2% | 4.0% | 0.4% | 1.8% | 1.0% | 1.0% | 0.3% | 0.1% | 0.1% | 84.2% |
RSV: Respiratory syncytial virus. hMPV: Human metapneumovirus.
hMPV was searched for only in 2014–2016.
It includes specimens that tested positive to more than one respiratory virus.
Not shown because of limited numbers: 406 specimens from the Oriente region and 93 specimens from the Galápagos Islands. Information on the region was not available for 32 specimens.
“Universal” surveillance scheme: ILI and SARI patients seen at all hospitals, local health units, airports and harbours in the country from week 20/2009 to week 09/2011. “Sentinel” surveillance scheme: SARI patients seen at selected hospitals and health units from week 10/2011 to week 52/2016. See text for detail.
Information on patient’s gender was not available for 64 specimens.
Information on patient’s age was not available for 58 specimens.